What Is a Biomarker?
Learn what a biomarker is in biotech, how biomarkers are used in trials, and why biomarker news matters for drug development and investing.
Blog Tag
7 articles tagged with Biotech Data. The newest post is from Apr 8, 2026.
Learn what a biomarker is in biotech, how biomarkers are used in trials, and why biomarker news matters for drug development and investing.
Learn what a secondary endpoint is, how it supports clinical trial interpretation, and why it matters in biotech data releases.
Learn what a primary endpoint is, why it matters most in clinical trials, and how investors use it to judge biotech readouts.
Learn what a clinical trial endpoint is, why endpoints matter in biotech, and how they shape the interpretation of trial results and news.
Learn what data lock means in biotech, why it matters before a clinical readout, and how it affects timing, confidence, and news flow.
Learn why clinical trial timelines change, what causes delays in biotech, and how news systems can track shifting readout and enrollment dates.
Learn what a clinical trial readout is, what investors look for in biotech data releases, and why readouts often move stocks and market sentiment.